The University of Chicago Header Logo

Connection

Mark Ferguson to Female

Back to Details
This is a "connection" page, showing publications Mark Ferguson has written about Female.
Mark Ferguson
Connection Strength
1.074
Female
  1. The risk analysis index is an independent predictor of outcomes after lung cancer resection. PLoS One. 2024; 19(5):e0303281.
    View in: PubMed
    Score: 0.045
  2. Gender Bias in Judging Frailty and Fitness for Lung Surgery. Ann Thorac Surg. 2023 02; 115(2):356-361.
    View in: PubMed
    Score: 0.038
  3. A Morphomic Index Is an Independent Predictor of Survival After Lung Cancer Resection. Ann Thorac Surg. 2020 03; 109(3):873-878.
    View in: PubMed
    Score: 0.033
  4. Gender Bias Affects Assessment of Frailty and Recommendations for Surgery. Ann Thorac Surg. 2020 03; 109(3):938-944.
    View in: PubMed
    Score: 0.033
  5. Physician Gender Differences in Processing Surgical Risk Features in Videos of Standardized Patients. Ann Thorac Surg. 2019 04; 107(4):1248-1252.
    View in: PubMed
    Score: 0.031
  6. Do Estimates of Treatment Risk Based on Clinical Vignettes Differ by Physician Gender? Ann Thorac Surg. 2018 12; 106(6):1868-1872.
    View in: PubMed
    Score: 0.031
  7. Does Race Influence Risk Assessment and Recommendations for Lung Resection? A Randomized Trial. Ann Thorac Surg. 2018 10; 106(4):1013-1017.
    View in: PubMed
    Score: 0.030
  8. The Influence of Physician and Patient Gender on Risk Assessment for Lung Cancer Resection. Ann Thorac Surg. 2017 Jul; 104(1):284-289.
    View in: PubMed
    Score: 0.028
  9. Screening for Frailty in Thoracic Surgical Patients. Ann Thorac Surg. 2017 Mar; 103(3):956-961.
    View in: PubMed
    Score: 0.027
  10. Lung function predicts pulmonary complications regardless of the surgical approach. Ann Thorac Surg. 2015 May; 99(5):1761-7.
    View in: PubMed
    Score: 0.024
  11. Reply: To PMID 24565405. Ann Thorac Surg. 2014 Oct; 98(4):1525-6.
    View in: PubMed
    Score: 0.023
  12. Thoracic surgeons' perception of frail behavior in videos of standardized patients. PLoS One. 2014; 9(6):e98654.
    View in: PubMed
    Score: 0.023
  13. The impact of perceived frailty on surgeons' estimates of surgical risk. Ann Thorac Surg. 2014 Jul; 98(1):210-6.
    View in: PubMed
    Score: 0.023
  14. Prediction of major cardiovascular events after lung resection using a modified scoring system. Ann Thorac Surg. 2014 Apr; 97(4):1135-40.
    View in: PubMed
    Score: 0.022
  15. Association of body mass index and outcomes after major lung resection. Eur J Cardiothorac Surg. 2014 Apr; 45(4):e94-9; discussion e99.
    View in: PubMed
    Score: 0.022
  16. Competence versus mastery: the time course for developing proficiency in video-assisted thoracoscopic lobectomy. J Thorac Cardiovasc Surg. 2014 Apr; 147(4):1150-4.
    View in: PubMed
    Score: 0.022
  17. Predicted postoperative lung function is associated with all-cause long-term mortality after major lung resection for cancer. Eur J Cardiothorac Surg. 2014 Apr; 45(4):660-4.
    View in: PubMed
    Score: 0.022
  18. Editorial comment: inflationary pressures. Eur J Cardiothorac Surg. 2012 Sep; 42(3):403-4.
    View in: PubMed
    Score: 0.020
  19. Validation of a modified scoring system for cardiovascular risk associated with major lung resection. Eur J Cardiothorac Surg. 2012 Mar; 41(3):598-602.
    View in: PubMed
    Score: 0.019
  20. Assessment of a scoring system for predicting complications after esophagectomy. Dis Esophagus. 2011 Sep; 24(7):510-5.
    View in: PubMed
    Score: 0.018
  21. Editorial comment: Back to the future: chest physiotherapy comes full circle. Eur J Cardiothorac Surg. 2011 Jul; 40(1):134-5.
    View in: PubMed
    Score: 0.018
  22. Estimating lung resection risk: a pilot study of trainee and practicing surgeons. Ann Thorac Surg. 2010 Apr; 89(4):1037-42; discussion 1042-3.
    View in: PubMed
    Score: 0.017
  23. Pulmonary complications after lung resection in the absence of chronic obstructive pulmonary disease: the predictive role of diffusing capacity. J Thorac Cardiovasc Surg. 2009 Dec; 138(6):1297-302.
    View in: PubMed
    Score: 0.016
  24. Quality of life and mood in older patients after major lung resection. Ann Thorac Surg. 2009 Apr; 87(4):1007-12; discussion 1012-3.
    View in: PubMed
    Score: 0.016
  25. Modeling major lung resection outcomes using classification trees and multiple imputation techniques. Eur J Cardiothorac Surg. 2008 Nov; 34(5):1085-9.
    View in: PubMed
    Score: 0.015
  26. Diffusing capacity predicts morbidity after lung resection in patients without obstructive lung disease. Ann Thorac Surg. 2008 Apr; 85(4):1158-64; discussion 1164-5.
    View in: PubMed
    Score: 0.015
  27. Bowel necrosis associated with early jejunal tube feeding: A complication of postoperative enteral nutrition. Arch Surg. 2006 Jul; 141(7):701-4.
    View in: PubMed
    Score: 0.013
  28. Induction therapy does not increase surgical morbidity after esophagectomy for cancer. Ann Thorac Surg. 2004 Nov; 78(5):1783-9.
    View in: PubMed
    Score: 0.012
  29. Implementing a Frailty-Specific Postoperative Order Set to Improve Postoperative Outcomes in Frail Adults After Elective Thoracic Surgery. J Nurs Care Qual. 2024 Oct-Dec 01; 39(4):361-368.
    View in: PubMed
    Score: 0.011
  30. Barriers and facilitators to smartwatch-based prehabilitation participation among frail surgery patients: a qualitative study. BMC Geriatr. 2024 02 02; 24(1):129.
    View in: PubMed
    Score: 0.011
  31. Germline Variants Incidentally Detected via Tumor-Only Genomic Profiling of Patients With Mesothelioma. JAMA Netw Open. 2023 08 01; 6(8):e2327351.
    View in: PubMed
    Score: 0.011
  32. Postpneumonectomy pulmonary edema. J Cardiothorac Vasc Anesth. 2003 Jun; 17(3):388-95.
    View in: PubMed
    Score: 0.011
  33. A comparison of three scoring systems for predicting complications after major lung resection. Eur J Cardiothorac Surg. 2003 Jan; 23(1):35-42.
    View in: PubMed
    Score: 0.010
  34. Preoperative prediction of the risk of pulmonary complications after esophagectomy for cancer. J Thorac Cardiovasc Surg. 2002 Apr; 123(4):661-9.
    View in: PubMed
    Score: 0.010
  35. Long-term survival after esophagectomy for Barrett's adenocarcinoma in endoscopically surveyed and nonsurveyed patients. J Gastrointest Surg. 2002 Jan-Feb; 6(1):29-35; discussion 36.
    View in: PubMed
    Score: 0.010
  36. CDKN2A loss-of-function predicts immunotherapy resistance in non-small cell lung cancer. Sci Rep. 2021 10 08; 11(1):20059.
    View in: PubMed
    Score: 0.009
  37. Risk Prediction Model of 90-Day Mortality After Esophagectomy for Cancer. JAMA Surg. 2021 09 01; 156(9):836-845.
    View in: PubMed
    Score: 0.009
  38. U.S. trends in elective and emergent major abdominal surgical procedures from 2002 to 2014 in older adults. J Am Geriatr Soc. 2021 08; 69(8):2220-2230.
    View in: PubMed
    Score: 0.009
  39. Clinical predictors of donor antibody titre and correlation with recipient antibody response in a COVID-19 convalescent plasma clinical trial. J Intern Med. 2021 04; 289(4):559-573.
    View in: PubMed
    Score: 0.009
  40. Long-term outcome after resection for bronchial carcinoid tumors. Eur J Cardiothorac Surg. 2000 Aug; 18(2):156-61.
    View in: PubMed
    Score: 0.009
  41. Does pneumonectomy for lung cancer adversely influence long-term survival? J Thorac Cardiovasc Surg. 2000 Mar; 119(3):440-8.
    View in: PubMed
    Score: 0.008
  42. Evaluation of the Association of Perioperative UGT1A1 Genotype-Dosed gFOLFIRINOX With Margin-Negative Resection Rates and Pathologic Response Grades Among Patients With Locally Advanced Gastroesophageal Adenocarcinoma: A Phase 2 Clinical Trial. JAMA Netw Open. 2020 02 05; 3(2):e1921290.
    View in: PubMed
    Score: 0.008
  43. Sex-associated differences in survival of patients undergoing resection for lung cancer. Ann Thorac Surg. 2000 Jan; 69(1):245-9; discussion 249-50.
    View in: PubMed
    Score: 0.008
  44. Diffusing capacity predicts operative mortality but not long-term survival after resection for lung cancer. J Thorac Cardiovasc Surg. 1999 Mar; 117(3):581-6; discussion 586-7.
    View in: PubMed
    Score: 0.008
  45. Translating Frailty Research Into Clinical Practice: Insights From the Successful Aging and Frailty Evaluation Clinic. J Am Med Dir Assoc. 2019 06; 20(6):672-678.
    View in: PubMed
    Score: 0.008
  46. Resection for Barrett's mucosa with high-grade dysplasia: implications for prophylactic photodynamic therapy. J Thorac Cardiovasc Surg. 1997 Nov; 114(5):824-9.
    View in: PubMed
    Score: 0.007
  47. Effect of Endoscopic Bronchial Ultrasound on Outcomes for Stage I Non-Small-Cell Lung Cancer Patients Receiving Hypofractionated Radiotherapy. Clin Lung Cancer. 2018 03; 19(2):e227-e233.
    View in: PubMed
    Score: 0.007
  48. Coronary artery disease is associated with an increased mortality rate following video-assisted thoracoscopic lobectomy. J Thorac Cardiovasc Surg. 2017 07; 154(1):352-357.
    View in: PubMed
    Score: 0.007
  49. Risk-stratifying capacity of PET/CT metabolic tumor volume in stage IIIA non-small cell lung cancer. Eur J Nucl Med Mol Imaging. 2017 Aug; 44(8):1275-1284.
    View in: PubMed
    Score: 0.007
  50. Prognostic value of quantitative PET/CT in patients with a nonsmall cell lung cancer and another primary cancer. Nucl Med Commun. 2017 Feb; 38(2):185-192.
    View in: PubMed
    Score: 0.007
  51. Outcome after failed initial therapy for rupture of the esophagus or intrathoracic stomach. J Gastrointest Surg. 1997 Jan-Feb; 1(1):34-9.
    View in: PubMed
    Score: 0.007
  52. Use of pleural catheter for the management of simple pneumothorax. Chest. 1996 Nov; 110(5):1169-72.
    View in: PubMed
    Score: 0.007
  53. Results of myotomy and partial fundoplication after pneumatic dilation for achalasia. Ann Thorac Surg. 1996 Aug; 62(2):327-30.
    View in: PubMed
    Score: 0.007
  54. Limitations of PET/CT in the Detection of Occult N1 Metastasis in Clinical Stage I(T1-2aN0) Non-Small Cell Lung Cancer for Staging Prior to Stereotactic Body Radiotherapy. Technol Cancer Res Treat. 2017 02; 16(1):15-21.
    View in: PubMed
    Score: 0.007
  55. Comprehensive genetic testing identifies targetable genomic alterations in most patients with non-small cell lung cancer, specifically adenocarcinoma, single institute investigation. Oncotarget. 2016 Apr 05; 7(14):18876-86.
    View in: PubMed
    Score: 0.006
  56. Doubling of 30-Day Mortality by 90 Days After Esophagectomy: A Critical Measure of Outcomes for Quality Improvement. Ann Surg. 2016 Feb; 263(2):286-91.
    View in: PubMed
    Score: 0.006
  57. Retroperitoneal placement of an ICD generator: a solution for a difficult problem. Pacing Clin Electrophysiol. 1996 Jan; 19(1):130-1.
    View in: PubMed
    Score: 0.006
  58. Right Ventricular Apical Flattening as an Echocardiographic Screening Tool for Right Ventricular Enlargement. Pediatr Cardiol. 2016 Mar; 37(3):568-74.
    View in: PubMed
    Score: 0.006
  59. Current results of therapy for esophageal perforation. Am J Surg. 1995 Jun; 169(6):615-7.
    View in: PubMed
    Score: 0.006
  60. Thoracic Revised Cardiac Risk Index Is Associated With Prognosis After Resection for Stage I Lung Cancer. Ann Thorac Surg. 2015 Jul; 100(1):195-200.
    View in: PubMed
    Score: 0.006
  61. Intensive multimodality therapy for carcinoma of the esophagus and gastroesophageal junction. Ann Surg Oncol. 1995 Mar; 2(2):101-6.
    View in: PubMed
    Score: 0.006
  62. External validation of the Ferguson pulmonary risk score for predicting major pulmonary complications after oesophagectomy†. Eur J Cardiothorac Surg. 2016 Jan; 49(1):333-8.
    View in: PubMed
    Score: 0.006
  63. Optimizing selection of patients for major lung resection. J Thorac Cardiovasc Surg. 1995 Feb; 109(2):275-81; discussion 281-3.
    View in: PubMed
    Score: 0.006
  64. How accurate are anatomic landmarks for femoral tunnel positioning in anterior cruciate ligament reconstruction? An in vivo imaging analysis comparing both anteromedial portal and outside-in techniques. Arthroscopy. 2015 May; 31(5):882-9.
    View in: PubMed
    Score: 0.006
  65. Modulation of lymphatic spontaneous contractions by EDRF. J Surg Res. 1994 Jun; 56(6):620-5.
    View in: PubMed
    Score: 0.006
  66. Characterization of contractile properties of porcine mesenteric and tracheobronchial lymphatic smooth muscle. Lymphology. 1994 Jun; 27(2):71-81.
    View in: PubMed
    Score: 0.006
  67. Nitric oxide and endothelium-dependent relaxation in tracheobronchial lymph vessels. Microvasc Res. 1994 May; 47(3):308-17.
    View in: PubMed
    Score: 0.006
  68. Complete endoscopic mucosal resection is effective and durable treatment for Barrett's-associated neoplasia. Clin Gastroenterol Hepatol. 2014 Dec; 12(12):2002-10.e1-2.
    View in: PubMed
    Score: 0.006
  69. Transcervical thymectomy for myasthenia gravis. Ann Thorac Surg. 1994 Jan; 57(1):194-7.
    View in: PubMed
    Score: 0.006
  70. Heterogeneity of tracheobronchial lymphatic smooth muscle responses to histamine and 5-hydroxytryptamine. Lymphology. 1993 Sep; 26(3):113-9.
    View in: PubMed
    Score: 0.005
  71. Improved survival associated with neoadjuvant chemoradiation in patients with clinical stage IIIA(N2) non-small-cell lung cancer. J Thorac Oncol. 2013 Jul; 8(7):915-22.
    View in: PubMed
    Score: 0.005
  72. Length-tension characteristics of bovine tracheobronchial lymphatic smooth muscle. Lymphology. 1993 Mar; 26(1):19-24.
    View in: PubMed
    Score: 0.005
  73. Adenocarcinoma in Barrett's esophagus. Semin Thorac Cardiovasc Surg. 1992 Oct; 4(4):276-9.
    View in: PubMed
    Score: 0.005
  74. Modulation of lymphatic smooth muscle contractile responses by the endothelium. J Surg Res. 1992 Apr; 52(4):359-63.
    View in: PubMed
    Score: 0.005
  75. Pathologic response rates following definitive dose image-guided chemoradiotherapy and resection for locally advanced non-small cell lung cancer. Lung Cancer. 2011 Dec; 74(3):446-50.
    View in: PubMed
    Score: 0.005
  76. MET and phosphorylated MET as potential biomarkers in lung cancer. J Environ Pathol Toxicol Oncol. 2011; 30(4):341-54.
    View in: PubMed
    Score: 0.004
  77. Predicting failure following shunting of pleural effusions. Chest. 1990 Oct; 98(4):890-3.
    View in: PubMed
    Score: 0.004
  78. Long-term outcome of a phase II study of docetaxel-based multimodality chemoradiotherapy for locally advanced carcinoma of the esophagus or gastroesophageal junction. Med Oncol. 2011 Dec; 28 Suppl 1:S152-61.
    View in: PubMed
    Score: 0.004
  79. Sex-associated differences in presentation and survival in patients with lung cancer. J Clin Oncol. 1990 Aug; 8(8):1402-7.
    View in: PubMed
    Score: 0.004
  80. Does induction treatment increase the risk of morbidity and mortality after pneumonectomy? A multicentre case-matched analysis. Eur J Cardiothorac Surg. 2010 Mar; 37(3):535-9.
    View in: PubMed
    Score: 0.004
  81. Ethnic differences and functional analysis of MET mutations in lung cancer. Clin Cancer Res. 2009 Sep 15; 15(18):5714-23.
    View in: PubMed
    Score: 0.004
  82. Early evaluation and therapy for caustic esophageal injury. Am J Surg. 1989 Jan; 157(1):116-20.
    View in: PubMed
    Score: 0.004
  83. Diffusing capacity predicts morbidity and mortality after pulmonary resection. J Thorac Cardiovasc Surg. 1988 Dec; 96(6):894-900.
    View in: PubMed
    Score: 0.004
  84. Lymphatic vessel density is not associated with lymph node metastasis in non-small cell lung carcinoma. Arch Pathol Lab Med. 2008 Dec; 132(12):1882-8.
    View in: PubMed
    Score: 0.004
  85. A scoring system predicting the risk for intensive care unit admission for complications after major lung resection: a multicenter analysis. Ann Thorac Surg. 2008 Jul; 86(1):213-8.
    View in: PubMed
    Score: 0.004
  86. Phase I study of induction chemotherapy and concomitant chemoradiotherapy with irinotecan, carboplatin, and paclitaxel for stage III non-small cell lung cancer. J Thorac Oncol. 2008 Jan; 3(1):59-67.
    View in: PubMed
    Score: 0.004
  87. Selective operative approach for diagnosis and treatment of anterior mediastinal masses. Ann Thorac Surg. 1987 Dec; 44(6):583-6.
    View in: PubMed
    Score: 0.004
  88. Chemotherapy and high dose radiotherapy followed by resection for locally advanced nonsmall cell lung cancers. Am J Clin Oncol. 2007 Jun; 30(3):258-63.
    View in: PubMed
    Score: 0.004
  89. Phase I study of vinorelbine, cisplatin, and concomitant thoracic radiation in the treatment of advanced chest malignancies. J Clin Oncol. 1998 Jun; 16(6):2157-63.
    View in: PubMed
    Score: 0.002
  90. Induction chemotherapy, surgery, and concomitant chemoradiotherapy for carcinoma of the esophagus: a long-term analysis. Ann Oncol. 1998 Jun; 9(6):647-51.
    View in: PubMed
    Score: 0.002
  91. Management of giant paraesophageal hernia. Dis Esophagus. 1997 Jan; 10(1):47-50.
    View in: PubMed
    Score: 0.002
  92. Vinorelbine (Navelbine), cisplatin, and concomitant radiation therapy for advanced malignancies of the chest: a Phase I study. Semin Oncol. 1996 Apr; 23(2 Suppl 5):48-52.
    View in: PubMed
    Score: 0.002
  93. A phase I trial of concomitant chemoradiotherapy with cisplatin dose intensification and granulocyte-colony stimulating factor support for advanced malignancies of the chest. Cancer Chemother Pharmacol. 1995; 35(4):304-12.
    View in: PubMed
    Score: 0.001
  94. Dedifferentiated chordoma. Response to aggressive chemotherapy in two cases. Cancer. 1993 Aug 01; 72(3):714-8.
    View in: PubMed
    Score: 0.001
  95. Forequarter amputation wound coverage with an ipsilateral, lymphedematous, circumferential forearm fasciocutaneous free flap in patients undergoing palliative shoulder-girdle tumor resection. J Reconstr Microsurg. 1993 Mar; 9(2):103-7.
    View in: PubMed
    Score: 0.001
  96. The impact on survival by adjuvant chemotherapy and radiation therapy in stage II non-small-cell lung cancer. Am J Clin Oncol. 1992 Oct; 15(5):405-11.
    View in: PubMed
    Score: 0.001
  97. Pericardial window: mechanisms of efficacy. Ann Thorac Surg. 1990 Sep; 50(3):442-5.
    View in: PubMed
    Score: 0.001
  98. 5-Fluorouracil with oral leucovorin and hydroxyurea and concomitant radiotherapy for stage III non-small cell lung cancer. Cancer. 1990 Aug 01; 66(3):437-42.
    View in: PubMed
    Score: 0.001
  99. Efficacy of computed tomography of the thorax and upper abdomen and whole-body gallium scintigraphy for staging of lung cancer. Cancer. 1989 Oct 01; 64(7):1404-8.
    View in: PubMed
    Score: 0.001
  100. Neoadjuvant vindesine, etoposide, and cisplatin for locally advanced non-small cell lung cancer. Final report of a phase 2 study. Chest. 1989 Jul; 96(1):110-3.
    View in: PubMed
    Score: 0.001
  101. Treatment of carcinoma of the proximal esophagus. Surg Gynecol Obstet. 1989 Apr; 168(4):307-10.
    View in: PubMed
    Score: 0.001
  102. Pleuro-peritoneal shunting. Alternative therapy for pleural effusions. Ann Surg. 1988 Oct; 208(4):443-50.
    View in: PubMed
    Score: 0.001
  103. Surgical management of esophageal strictures. Ann Thorac Surg. 1988 Feb; 45(2):144-7.
    View in: PubMed
    Score: 0.001
  104. Adenosquamous lung carcinoma: clinical characteristics, treatment, and prognosis. Ann Thorac Surg. 1987 Nov; 44(5):462-6.
    View in: PubMed
    Score: 0.001
  105. Colon interposition for benign esophageal disease. Surgery. 1987 Oct; 102(4):568-74.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.